Andy Page

Andy Page has an extensive work experience, spanning from 2005 to the present. Andy currently holds the position of Chief Operating Officer/Chief Business Officer at Grey Wolf Therapeutics since August 2023. Prior to that, they served as the Chief Operating Officer at Beckley Psytech from October 2020 to November 2022. From July 2019 to November 2020, Andy was the CEO and President of Otsuka Pharmaceutical Companies Europe. Andy also held various other roles at Otsuka, including Regional Vice President Commercial Excellence and CNS/Neurology Business Lead from December 2016 to June 2019 and UK Managing Director from August 2014 to December 2016. Before joining Otsuka, Andy worked at Johnson & Johnson as the Strategy and Market Development Director for EMEA Emerging Markets from August 2012 to August 2014. Andy began their career at Janssen-Cilag Ltd, where they held roles such as Business Unit Director from December 2009 to August 2012, Associate Director New Zealand from August 2007 to December 2009, and Group Product Manager from September 2005 to August 2007.

Andy Page graduated from the University of Leeds in 1994 with a BSc Hons degree in Pharmacology and Physiology. In 1999, they pursued further education at CIM | The Chartered Institute of Marketing and obtained a degree in Marketing, becoming a Chartered Marketer in 2002. Andy also attended MGSM Sydney in 2011 and 2012, but no specific degree or field of study information is provided.